Answers are grounded in this paper and cite their sources.
Clinical study evaluates cricoarytenoideus dorsalis myectomy outcomes in racehorses with laryngeal issues.
Objective To assess the clinical impact of the cricoarytenoideus dorsalis (CAD) myectomy in the short- and long-term postoperative abduction grade in racehorses. Methods Records from horses presented for surgical treatment of recurrent laryngeal neuropathy from January 2019 through December 2023 were divided into 2 groups: horses that received standard prosthetic laryngoplasty and horses that received a complete myectomy of the CAD (modified myectomy laryngoplasty). Outcomes were compared through endoscopic evaluation after anesthetic recovery, both short term (7 to 10 days) and long term (80 to 90 days). A retrospective review of clinical records was conducted, supplemented by a telephone questionnaire, designed to assess athletic performance and return to racing. Results There was a significantly higher grade of recurrent laryngeal neuropathy among older horses (4 to 5 years) compared to younger horses (2 to 3 years) at presentation. Age, however, did not influence the long-term outcomes. The modified myectomy laryngoplasty group exhibited significantly better long-term endoscopy grades, with 62.6% maintaining grade 2 abduction and superior grade retention (mean, 2.38) compared to those with PL alone (mean, 3.13). Conclusions Results support the hypothesis that removing the CAD muscle during surgery will minimize the dynamic impact to the prosthesis postoperative and decrease the likelihood of early and long-term loss of arytenoid abduction. Clinical Relevance Clinical findings can serve as reference point for future research to quantify the impact of CAD muscle in the loss of arytenoid abduction post operative in racehorses.
No takes yet. Share an insight, caveat, or question.
Verna et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: